Abstract：Objective To study the postnatal changes in lymphocyte subsets in early preterm infants and the effect of perinatal factors on lymphocyte subsets. Methods A total of 61 early preterm infants were enrolled. Flow cytometry was used to measure the absolute counts of lymphocytes and lymphocyte subsets at 1, 7, 14, and 28 days after birth, as well as at 6 months after birth for 17 of these early preterm infants. The effects of perinatal factors, such as antepartum use of hormone, intrauterine infection, gestational age at birth, and Ureaplasma urealyticum (UU) colonization, on lymphocyte subsets were analyzed. Results The absolute counts of lymphocyte subsets except natural killer (NK) cells were lowest at birth, increased rapidly at 1 week after birth, and reached the levels in healthy infants at 6 months; the count of NK cells remained at a low level and increased significantly at 6 months after birth. Compared with those with a gestational age of P P 0.05); the intrauterine infection group had significantly higher absolute counts of B cells at 7 and 14 days after birth than the non-infection group. Compared those without UU colonization, the infants with UU colonization had significantly higher absolute counts of lymphocytes, T cells, Th cells, and Ts cells at 1 day after birth and a significantly higher absolute count of B cells at 14 days after birth. Conclusions Early preterm infants have deficiencies in innate immune cells at birth and normal levels at about 6 months after birth. Various perinatal factors including antepartum use of hormone, gestational age at birth, intrauterine infection, and UU colonization have long-term effects on lymphocyte subsets in early preterm infants.
ZHOU Ping,CHEN Rui,ZOU Cai-Yan et al. Effect of perinatal factors on postnatal development of lymphocyte subsets in early preterm infants[J]. CJCP, 2016, 18(10): 953-959.
Azizia M, Lloyd J, Allen M, et al. Immune status in very preterm neonates[J]. Pediatrics, 2012, 129(4): e967-974.
[2]
Correa-Rocha R, Pérez A, Lorente R, et al. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7[J]. Pediatr Res, 2012, 71(5): 590-597.
[3]
Ma L, Chen R, Liu F, et al. Reduced NK cell percentage is associated with late onset infection in very preterm neonates[J]. Scand J Immunol, 2014, 80(1): 50-56.
Colombo F, Cattaneo A, Lopa R, et al. Evaluation of a multicolor, single-tube technique to enumerate lymphocyte subpopulations[J]. Clin Vaccine Immunol, 2008, 15(7): 1124-1127.
[6]
Walker JC, Smolders MA, Gemen EF, et al. Development of lymphocyte subpopulations in preterm infants[J]. Scand J Immunol, 2011, 73(1): 53-58.
[7]
Melville JM, Moss TJ. The immune consequences of preterm birth[J]. Front Neurosci, 2013, 7: 79.
[8]
Chabra S, Cottrill C, Rayens MK, et al. Lymphocyte subsets in cord blood of preterm infants: effect of antenatal steroids[J]. Biol Neonate, 1998, 74(3): 200-207.
[9]
Kavelaars A, van der Pompe G, Bakker JM, et al. Altered immune function in human newborns after prenatal administration of betamethasone: enhanced natural killer cell activity and decreased T cell proliferation in cord blood[J]. Pediatr Res, 1999, 45(3): 306-312.
[10]
Serwatowska-Bargieł A, Wąsik M, Katarzyna Kornacka M, et al. T-cell subpopulations αβ and γδ in cord blood of very preterm infants: the influence of intrauterine infection[J]. Arch Immunol Ther Exp (Warsz), 2013, 61(6): 495-501.
[11]
Berrington JE, Barge D, Fenton AC, et al. Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry[J]. Clin Exp Immunol, 2005, 140(2): 289-292.
[12]
Pelkonen AS, Suomalainen H, Hallman M, et al. Peripheral blood lymphocyte subpopulations in schoolchildren born very preterm[J]. Arch Dis Child Fetal Neonatal Ed, 1999, 81(3): F188-193.
[13]
Kotiranta-Ainamo A, Apajasalo M, Pohjavuori M, et al. Mononuclear cell subpopulations in preterm and full term neonates: independent effect of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethason therapy, and mode of delivery[J]. Clin Exp Immunol, 1999, 115(2): 309-314.
